Cell Analysis Market Growth, Analysis, Trends to 2023

The global cell analysis market size was valued at USD 17,500.0 million in 2022 and is poised to grow at a significant CAGR of 10.4% during the forecast period 2023-29. The rising awareness of the prognosis of cancer, newly emerging infectious diseases, rise in expenditure and investment in R&D for disease diagnosis and drug discovery are major drivers controlling the cell analysis market. Furthermore, cell analysis techniques are used increasingly for global healthcare settings varying from simple chromogenic stains for blood count, malaria to higher multiplexing techniques such as PCR, NGS for cancer diagnosis, immunoprofiling as they provide a more efficient and accurate diagnosis. Moreover, because of rigorous research and advancement in the cell analysis market, better availability of diagnostic tools and techniques, disease awareness among the public, increase in competition among leading market players cell analysis market is predicted to thrive over the forecast years.

View the detailed report description here https://www.precisionbusinessinsights.com/market-reports/cell-analysis-market

The cell analysis market is segmented based on the product, its application, techniques, end-user, and Geography.

Based on the product, the market is segmented into the following:
• Instruments
• Consumables and Reagents
• Software and Services

Based on application, the market is segmented into the following:
• Disease diagnosis
• Biomarker Discovery
• Drug discovery
• Personalized Medicine
• Others

Based on techniques, the market is segmented into the following:
• Flow Cytometry
• Spectrophotometry
• PCR
• Next Generation Sequencing
• Microscope
• Microarray
• Blotting techniques
• Others

Based on End User, the market is segmented into the following:
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Diagnostic Centres

Based on Geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA
• Rest of MEA

Next-generation sequencing segment is anticipated to show a significant growth rate in the market in upcoming years. NGS is used to identify novel mutations, biomarkers and chromosomal translocations. Ion torrent and Illumina systems are used profusely for clinical diagnosis in the short term. It contributes to the diagnosis of complex genetic diseases like cardiomyopathy, cardiac arrhythmia, mental retardation, disorder of sex development and therapeutic decision-making for somatic cancer. According to a research study, 85% of diseases related to mutation are present within the exome, WES (Whole exome sequencing) enables the identification of such novel mutation for complex diseases like primary immunodeficiency, psychiatric, autoimmune and neurodegenerative disorders, chromosomal translocation and copy number variation (CNS). According to a research article, WES enables the diagnosis of rare diseases, when combined that affect more than 300 million people worldwide. NGS helps in comprehending a person's genetic profile and disease biology and generates personalized medicine. As a result of the high frequency of increase in genetic diseases, demand for early diagnosis by NGS is predicted to rise, leading to market expansion.

North America Leads Cell Analysis Market
Cell analysis market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Currently, the North America cell analysis market is dominating the market owing to the prominent healthcare systems, well-developed labs and clinics, vigilant people, tremendous investment by the government in the R&D sector and developed infrastructure. It is followed by Europe with a significant cell analysis market. Moreover, the Asia Pacific cell analysis market is rising tremendously owing to the increased awareness about infectious diseases among individuals, increased investment by the government in the health sector, awareness campaigns run by government and NGOs, developing infrastructure, and cutthroat competition among companies to launch better and cheaper products for the increasing population. The Asia Pacific cell analysis market is poised to grow at the highest CAGR over the forecasted years.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players

Cell analysis market further reveals that the key players increasingly adopting strategies such as the launch of newer products, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In January 2023, Agilent Technologies announced a partnership with Akoya Biosciences to develop chromogenic and immunofluorescent assays for the analysis of cancer and the development of precision cancer therapeutics.

Key player's profiles in the Cell analysis Market report are Thermo Fisher Scientific (US), Agilent Technologies (US), Sigma-Aldrich (US), Sartorius (Germany), Enzo Life Sciences (US), Dickinson and Company (US), Danaher Corporation (US), Bio-Rad Laboratories (US), Promega Corporation (US), Illumina (US), Merck (US), Olympus Life Science (Japan), QIAGEN (US), CELLINK (US), PerkinElmer Inc. (US)

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=602642

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.